FXR1 and cancer: Notably, Fxr1 is overexpressed in several cancers and its expression correlates with poor prognosis in patients with lung squamous cell carcinoma, as well as non-small cell lung cancer, ovarian cancer, breast cancer, and head and neck squamous cell carcinoma (HNSCC)11, 12.